Archive for February 2nd, 2012

ARNA Advisory Committee expected 2Q 2012 + NAVB SCMP MRNA APPY news

Feb 02, 2012 No Comments by

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today that the Endocrinologic and Metabolic Drugs Advisory Committee expects to discuss the lorcaserin New Drug Application (NDA) resubmission for obesity during 2Q 2012. The PDUFA target date is June 27, 2012. Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) said that it intends to file a Marketing Authorization Application (MAA) in the EU […]

Daily News Read more